Reference drugs for triple combination test drug in Russia [Design Issues]

posted by Yura – Belarus, 2019-11-19 21:51 (427 d 00:33 ago) – Posting: # 20830
Views: 3,095

(edited by mittyri on 2019-11-19 22:50)

Hi Beholder,
There is no reason for the regulator not to want to check section 4.5 of the Guideline on clinical development of fixed combination medicinal products :|>
Kind regards,
Yura


Edit: Guideline linked. Also changed the name in signature to the usual one[Mittyri]

Complete thread:

Activity
 Admin contact
21,306 posts in 4,443 threads, 1,488 registered users;
online 8 (0 registered, 8 guests [including 5 identified bots]).
Forum time: Tuesday 22:25 CET (Europe/Vienna)

Science is what you know.
Philosophy is what you don’t know.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5